Evidence map›Paper›PMID 30875566›Full record

ArticleNeoplasia (New York, N.Y.)2019

Preclinical Prevention Trial of Calcitriol: Impact of Stage of Intervention and Duration of Treatment on Oral Carcinogenesis.

Vui King Vincent-Chong, Hendrik DeJong, Kristopher Attwood, Pamela A Hershberger, Mukund Seshadri

Open access · goldAbstract read
In one paragraph

Article in Neoplasia (New York, N.Y.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Chemopreventive Potential of Artemisinin andInternational journal of molecular sciences · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Impact of dietary vitamin D on initiation and progression of oral cancer.The Journal of steroid biochemistry and molecular biology · 2020
    Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Vui King Vincent-ChongDepartment of Oral Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York 14263.
Hendrik DeJongDepartment of Oral Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York 14263.
Kristopher AttwoodDepartment of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York 14263.
Pamela A HershbergerDepartment of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York 14263.
Mukund SeshadriDepartment of Oral Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York 14263; Department of Dentistry and Maxillofacial Prosthetics, Roswell Park Comprehensive Cancer Center, Buffalo, New York 14263. Electronic address: Mukund.Seshadri@roswellpark.org.
Roswell Park Comprehensive Cancer Center · US

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI Dean G. Tang · 1985 to 2026
$116.6M
Impact of Vitamin D on the Chemopreventive Efficacy of Erlotinib against Oral CancerR01DE024595 · NIDCR · ROSWELL PARK CANCER INSTITUTE CORP · PI SESHADRI, MUKUND · 2016 to 2020
$2.4M
NCI NIH HHS P30 CA016056NIDCR NIH HHS R01 DE024595
6 · The paper itself

Abstract

The anticancer activity of 1,25-dihydroxyvitamin D3 (1,25(OH)

Indexed as

AnimalsBiomarkersCalcitriolCalcium-Regulating Hormones and AgentsCell Transformation, NeoplasticDisease Models, AnimalDisease ProgressionDrug Evaluation, PreclinicalFemaleHumansImmunohistochemistryMagnetic Resonance ImagingMiceMouth NeoplasmsPhenotypeBiomarkersCalcitriolCalcium-Regulating Hormones and Agents

Identifiers

PMID30875566
PMCPMC6416727
OpenAlexW2921591146

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.